Citations (150)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Kristen Triebel, Joseph Anderson, Sai Rashmi Nakkina & David E Vance. (2021) Can Breast Cancer Survivors Benefit from Speed of Processing Training? A Perspective Article on Treatment and Research. Nursing: Research and Reviews 11, pages 9-20.
Read now
Read now
Kamal Yavari & Lida Kooshesh. (2019) Deuterium Depleted Water Inhibits the Proliferation of Human MCF7 Breast Cancer Cell Lines by Inducing Cell Cycle Arrest. Nutrition and Cancer 71:6, pages 1019-1029.
Read now
Read now
Siobhan M. Heiden & Barrett S. Caldwell. (2018) Considerations for developing chronic care system for traumatic brain injury based on comparisons of cancer survivorship and diabetes management care. Ergonomics 61:1, pages 134-147.
Read now
Read now
TanyaR. Fitzpatrick, Linda Edgar & Christina Holcroft. (2012) Assessing the Relationship Between Physical Fitness Activities, Cognitive Health, and Quality of Life Among Older Cancer Survivors. Journal of Psychosocial Oncology 30:5, pages 556-572.
Read now
Read now
Katharine
J. Vearncombe, Margaret Rolfe, Brooke Andrew, Nancy
A. Pachana, Margaret Wright & Geoffrey Beadle. (2011)
Cognitive Effects of Chemotherapy-Induced Menopause in Breast Cancer. The Clinical Neuropsychologist 25:8, pages 1295-1313.
Read now
Read now
Bernadine Cimprich, Patricia Reuter-Lorenz, James Nelson, Patricia
M. Clark, Barbara Therrien, Daniel Normolle, Marc
G. Berman, Daniel
F. Hayes, Douglas
C. Noll, Scott Peltier & Robert
C. Welsh. (2010) Prechemotherapy alterations in brain function in women with breast cancer. Journal of Clinical and Experimental Neuropsychology 32:3, pages 324-331.
Read now
Read now
StephanieA. Reid-Arndt, Albert Yee, MichaelC. Perry & Catherine Hsieh. (2009) Cognitive and Psychological Factors Associated with Early Posttreatment Functional Outcomes in Breast Cancer Survivors. Journal of Psychosocial Oncology 27:4, pages 415-434.
Read now
Read now
Pia Svedberg, Margaret Gatz & NancyL. Pedersen. (2009) Genetic and Environmental Mediation of the Associations Between Self-rated Health and Cognitive Abilities. Experimental Aging Research 35:2, pages 178-201.
Read now
Read now
StevenA. Castellon, PatriciaA. Ganz, JulienneE. Bower, Laura Petersen, Laura Abraham & GailA. Greendale. (2004) Neurocognitive Performance in Breast Cancer Survivors Exposed to Adjuvant Chemotherapy and Tamoxifen. Journal of Clinical and Experimental Neuropsychology 26:7, pages 955-969.
Read now
Read now
Victor T. Chang & Jane Ingham. (2003) Symptom Control. Cancer Investigation 21:4, pages 564-578.
Read now
Read now
Articles from other publishers (140)
Mika Miyashita. (2023) Chemotherapy-related cognitive impairment: what we need to know and what we can do. Asia-Pacific Journal of Oncology Nursing, pages 100334.
Crossref
Crossref
Dan Fayette, Veronika Juríčková, Tomáš Kozák, Heidi Mociková, Lubica Gaherová, Iveta Fajnerová & Jiří Horáček. (2023) Cognitive impairment associated with Hodgkin’s lymphoma and chemotherapy. Neuroscience Letters 797, pages 137082.
Crossref
Crossref
Samuel M. Miller, Lauren E. Wilson, Melissa A. Greiner, Jessica E. Pritchard, Tian Zhang, Deborah R. Kaye, Harvey Jay Cohen, Robert D. Becher, Linda L. Maerz & Michaela A. Dinan. (2022) Evaluation of mild cognitive impairment and dementia in patients with metastatic renal cell carcinoma. Journal of Geriatric Oncology 13:5, pages 635-643.
Crossref
Crossref
Giovana R. Onzi, Nathalia D’Agustini, Solange C. Garcia, Silvia S. Guterres, Paula R. Pohlmann, Daniela D. Rosa & Adriana R. Pohlmann. (2022) Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions. Drug Safety 45:6, pages 601-621.
Crossref
Crossref
Shirin Jalili & Ramin Ghasemi Shayan. (2022) A Comprehensive Evaluation of Health-Related Life Quality Assessment Through Head and Neck, Prostate, Breast, Lung, and Skin Cancer in Adults. Frontiers in Public Health 10.
Crossref
Crossref
Sydney Weber Boutros, Destine Krenik, Sarah Holden, Vivek K. Unni & Jacob Raber. (2022) Common cancer treatments targeting DNA double strand breaks affect long-term memory and relate to immediate early gene expression in a sex-dependent manner. Oncotarget 13:1, pages 198-213.
Crossref
Crossref
Gilbert Youssef, Patrick Y. Wen & Eudocia Q. Lee. 2022. Neurological Complications of Systemic Cancer and Antineoplastic Therapy. Neurological Complications of Systemic Cancer and Antineoplastic Therapy
479
500
.
Melanie J. Sekeres, Meenakshie Bradley-Garcia, Alonso Martinez-Canabal & Gordon Winocur. (2021) Chemotherapy-Induced Cognitive Impairment and Hippocampal Neurogenesis: A Review of Physiological Mechanisms and Interventions. International Journal of Molecular Sciences 22:23, pages 12697.
Crossref
Crossref
C. Nieder. 2023. Advances in Radiation Oncology in Lung Cancer. Advances in Radiation Oncology in Lung Cancer
969
983
.
Florence D Mowlem, Brad Sanderson, Jill V Platko & Bill Byrom. (2020) Optimizing electronic capture of patient-reported outcome measures in oncology clinical trials: lessons learned from a qualitative study. Journal of Comparative Effectiveness Research 9:17, pages 1195-1204.
Crossref
Crossref
Neha P. Gothe, Emily D. Erlenbach, Samuel L. Streeter & Linda Lehovec. (2020) Effects of yoga, aerobic, and stretching and toning exercises on cognition in adult cancer survivors: protocol of the STAY Fit pilot randomized controlled trial. Trials 21:1.
Crossref
Crossref
Lien D Nguyen & Barbara E Ehrlich. (2020) Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases. EMBO Molecular Medicine 12:6.
Crossref
Crossref
Petra Huehnchen, Antonia van Kampen, Wolfgang Boehmerle & Matthias Endres. (2020) Cognitive impairment after cytotoxic chemotherapy. Neuro-Oncology Practice 7:1, pages 11-21.
Crossref
Crossref
Todd S Horowitz, Melissa Treviño, Ingrid M Gooch & Korrina A Duffy. (2019) Understanding the Profile of Cancer-Related Cognitive Impairments: A Critique of Meta-Analyses. JNCI: Journal of the National Cancer Institute 111:10, pages 1009-1015.
Crossref
Crossref
Valeria Sebri, Lucrezia Savioni, Stefano Triberti, Ketti Mazzocco & Gabriella Pravettoni. (2019) How to Train Your Health: Sports as a Resource to Improve Cognitive Abilities in Cancer Patients. Frontiers in Psychology 10.
Crossref
Crossref
Martin C. Tom, Daniel P. Cahill, Jan C. Buckner, Jörg Dietrich, Michael W. Parsons & Jennifer S. Yu. (2019) Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal?. American Society of Clinical Oncology Educational Book:39, pages 133-145.
Crossref
Crossref
Jennifer Blackwood. (2019) The Influence of Cognitive Function on Balance, Mobility, and Falls in Older Cancer Survivors. Rehabilitation Oncology 37:2, pages 77-82.
Crossref
Crossref
Jörg Dietrich, Sebastian F. Winter & Michael W. Parsons. 2019. Oncology of CNS Tumors. Oncology of CNS Tumors
751
767
.
Sara Emad El-Agamy, Amal Kamal Abdel-Aziz, Sara Wahdan, Ahmed Esmat & Samar S. Azab. (2017) Astaxanthin Ameliorates Doxorubicin-Induced Cognitive Impairment (Chemobrain) in Experimental Rat Model: Impact on Oxidative, Inflammatory, and Apoptotic Machineries. Molecular Neurobiology 55:7, pages 5727-5740.
Crossref
Crossref
Barbara W. Carlson, Melissa A. Craft, John R. Carlson, Wajeeha Razaq, Kelley K. Deardeuff & Doris M. Benbrook. (2018) Accelerated vascular aging and persistent cognitive impairment in older female breast cancer survivors. GeroScience 40:3, pages 325-336.
Crossref
Crossref
David Buchbinder, Debra Lynch Kelly, Rafael F. Duarte, Jeffery J. Auletta, Neel Bhatt, Michael Byrne, Zachariah DeFilipp, Melissa Gabriel, Anuj Mahindra, Maxim Norkin, Helene Schoemans, Ami J. Shah, Ibrahim Ahmed, Yoshiko Atsuta, Grzegorz W. Basak, Sara Beattie, Sita Bhella, Christopher Bredeson, Nancy Bunin, Jignesh Dalal, Andrew Daly, James Gajewski, Robert Peter Gale, John Galvin, Mehdi Hamadani, Robert J. Hayashi, Kehinde Adekola, Jason Law, Catherine J. Lee, Jane Liesveld, Adriana K. Malone, Arnon Nagler, Seema Naik, Taiga Nishihori, Susan K. Parsons, Angela Scherwath, Hannah-Lise Schofield, Robert Soiffer, Jeff Szer, Ida Twist, Anne B. Warwick, Baldeep M. Wirk, Jean Yi, Minoo Battiwalla, Mary D. E. Flowers, Bipin Savani & Bronwen E. Shaw. (2018) Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT. Bone Marrow Transplantation 53:5, pages 535-555.
Crossref
Crossref
Debra Lynch Kelly, David Buchbinder, Rafael F. Duarte, Jeffrey J. Auletta, Neel Bhatt, Michael Byrne, Zachariah DeFilipp, Melissa Gabriel, Anuj Mahindra, Maxim Norkin, Helene Schoemans, Ami J. Shah, Ibrahim Ahmed, Yoshiko Atsuta, Grzegorz W. Basak, Sara Beattie, Sita Bhella, Christopher Bredeson, Nancy Bunin, Jignesh Dalal, Andrew Daly, James Gajewski, Robert Peter Gale, John Galvin, Mehdi Hamadani, Robert J. Hayashi, Kehinde Adekola, Jason Law, Catherine J. Lee, Jane Liesveld, Adriana K. Malone, Arnon Nagler, Seema Naik, Taiga Nishihori, Susan K. Parsons, Angela Scherwath, Hannah-Lise Schofield, Robert Soiffer, Jeff Szer, Ida Twist, Anne Warwick, Baldeep M. Wirk, Jean Yi, Minoo Battiwalla, Mary E. Flowers, Bipin Savani & Bronwen E. Shaw. (2018) Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation 24:2, pages 228-241.
Crossref
Crossref
Holly J. Pederson & Jennifer R. Klemp. 2018. The Breast. The Breast
1049
1056.e4
.
Robert J. Ferguson, Catherine M. Bender, Brenna C. McDonald, James C. Root & Shelly Kucherer. 2018. Handbook of Cancer Survivorship. Handbook of Cancer Survivorship
199
225
.
Sivaprasad Punnaveetil & Preeja Prabhakar. 2018. Bioactive Components, Diet and Medical Treatment in Cancer Prevention. Bioactive Components, Diet and Medical Treatment in Cancer Prevention
187
199
.
Tanya R. Fitzpatrick. 2018. Quality of Life Among Cancer Survivors. Quality of Life Among Cancer Survivors
7
22
.
Isabel Arrillaga. 2018. Cancer Neurology in Clinical Practice. Cancer Neurology in Clinical Practice
617
625
.
Jörg Dietrich & Michael W. Parsons. 2018. Cancer Neurology in Clinical Practice. Cancer Neurology in Clinical Practice
203
219
.
Katie Veretennikoff, David Walker, Vivien Biggs & Gail Robinson. (2017) Changes in Cognition and Decision Making Capacity Following Brain Tumour Resection: Illustrated with Two Cases. Brain Sciences 7:12, pages 122.
Crossref
Crossref
Qing Wei, Ling Li, Xiao-Dong Zhu, Ling Qin, Yan-Lin Mo, Zheng-You Liang, Jia-Li Deng & Su-Ping Tao. (2017) Effects of intensity-modulated radiotherapy and chemoradiotherapy on attention in patients with nasopharyngeal cancer. Oncotarget 8:36, pages 60390-60400.
Crossref
Crossref
David E. Vance, Jennifer Sandson Frank, Jennifer Bail, Kristen L. Triebel, Lindsay M. Niccolai, Adam Gerstenecker & Karen Meneses. (2017) Interventions for Cognitive Deficits in Breast Cancer Survivors Treated With Chemotherapy. Cancer Nursing 40:1, pages E11-E27.
Crossref
Crossref
Annalynn M. Williams, Clive S. Zent & Michelle C. Janelsins. (2016) What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research. British Journal of Haematology 174:6, pages 835-846.
Crossref
Crossref
A. M. Williams, M. C. Janelsins & E. van Wijngaarden. (2015) Cognitive function in cancer survivors: analysis of the 1999–2002 National Health and Nutrition Examination Survey. Supportive Care in Cancer 24:5, pages 2155-2162.
Crossref
Crossref
Jeffrey S Wefel, Kyle R Noll & Michael E Scheurer. (2016) Neurocognitive functioning and genetic variation in patients with primary brain tumours. The Lancet Oncology 17:3, pages e97-e108.
Crossref
Crossref
P. Jean-Pierre & B.C. McDonald. 2016. Neuroepidemiology. Neuroepidemiology
297
309
.
Isabel Arrillaga-Romany, Michelle Monje & Patrick Y. Wen. 2016. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging
125
142
.
Michael J. Mackenzie, Krystle E. Zuniga & Edward McAuley. 2016. Exercise-Cognition Interaction. Exercise-Cognition Interaction
399
419
.
Jamie S. Myers, Jo A. Wick & Jennifer Klemp. (2015) Potential factors associated with perceived cognitive impairment in breast cancer survivors. Supportive Care in Cancer 23:11, pages 3219-3228.
Crossref
Crossref
Kaarin J. Anstey, Kerry Sargent-Cox, Nicolas Cherbuin & Perminder S. Sachdev. (2015) Self-Reported History of Chemotherapy and Cognitive Decline in Adults Aged 60 and Older: The PATH Through Life Project. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 70:6, pages 729-735.
Crossref
Crossref
Miyuki Ono, James M. Ogilvie, Jennifer S. Wilson, Heather J. Green, Suzanne K. Chambers, Tamara Ownsworth & David H. K. Shum. (2015) A Meta-Analysis of Cognitive Impairment and Decline Associated with Adjuvant Chemotherapy in Women with Breast Cancer. Frontiers in Oncology 5.
Crossref
Crossref
Mark Noble, Margot Mayer-Pröschel, Zaibo Li, Tiefei Dong, Wanchang Cui, Christoph Pröschel, Ibro Ambeskovic, Joerg Dietrich, Ruolan Han, Yin Miranda Yang, Christopher Folts, Jennifer Stripay, Hsing-Yu Chen & Brett M. Stevens. (2015) Redox biology in normal cells and cancer: Restoring function of the redox/Fyn/c-Cbl pathway in cancer cells offers new approaches to cancer treatment. Free Radical Biology and Medicine 79, pages 300-323.
Crossref
Crossref
Lyndel K. Shand, Joanne E. Brooker, Sue Burney, Jane Fletcher & Lina A. Ricciardelli. (2014) Symptoms of posttraumatic stress in Australian women with ovarian cancer. Psycho-Oncology 24:2, pages 190-196.
Crossref
Crossref
Laura L. Horky, Victor H. Gerbaudo, Alexander Zaitsev, Wen Plesniak, Jon Hainer, Usha Govindarajulu, Ron Kikinis & Jörg Dietrich. (2014) Systemic chemotherapy decreases brain glucose metabolism. Annals of Clinical and Translational Neurology 1:10, pages 788-798.
Crossref
Crossref
Kim Edelstein & Lori J. Bernstein. (2014) Cognitive Dysfunction after Chemotherapy For Breast Cancer. Journal of the International Neuropsychological Society 20:4, pages 351-356.
Crossref
Crossref
Lori J. Bernstein, Pamela A. Catton & Ian F. Tannock. (2014) Intra-individual Variability in Women with Breast Cancer. Journal of the International Neuropsychological Society 20:4, pages 380-390.
Crossref
Crossref
J.S. Fernandez-Moure, M. Evangelopoulos, S. Scaria, J.O. Martinez, B.S. Brown, A.C. Coronel, P. Chan, B. Weiner, M. Ferrari & E. Tasciotti. 2014. Porous Silicon for Biomedical Applications. Porous Silicon for Biomedical Applications
374
402
.
Jordan Sorokin, Babak Saboury, JinHyung Albert Ahn, Mateen Moghbel, Sandip Basu & Abass Alavi. (2014) Adverse Functional Effects of Chemotherapy on Whole-Brain Metabolism. Clinical Nuclear Medicine 39:1, pages e35-e39.
Crossref
Crossref
Ronald A. CohenRonald A. Cohen. 2014. The Neuropsychology of Attention. The Neuropsychology of Attention
491
523
.
Jamie S. Myers. (2013) Cancer- and Chemotherapy-Related Cognitive Changes: The Patient Experience. Seminars in Oncology Nursing 29:4, pages 300-307.
Crossref
Crossref
Catherine M. Bender & Bethany D. Thelen. (2013) Cancer and Cognitive Changes: The Complexity of the Problem. Seminars in Oncology Nursing 29:4, pages 232-237.
Crossref
Crossref
K M Phillips, H L McGinty, J Cessna, Y Asvat, B Gonzalez, M G Cases, B J Small, P B Jacobsen, J Pidala & H S L Jim. (2013) A systematic review and meta-analysis of changes in cognitive functioning in adults undergoing hematopoietic cell transplantation. Bone Marrow Transplantation 48:10, pages 1350-1357.
Crossref
Crossref
Hai Ping Zhao, Ying Liu, Hong Li Li, Li Ma, Yan Jun Zhang & Jing Wang. (2012) Activity limitation and participation restrictions of breast cancer patients receiving chemotherapy: psychometric properties and validation of the Chinese version of the WHODAS 2.0. Quality of Life Research 22:4, pages 897-906.
Crossref
Crossref
Carole Scherling & Andra Smith. (2013) Opening up the Window into “Chemobrain”: A Neuroimaging Review. Sensors 13:3, pages 3169-3203.
Crossref
Crossref
H. Taillia. (2013) Qu’en-est-il du chemobrain ?. Revue Neurologique 169:3, pages 216-222.
Crossref
Crossref
Patricia A. Reuter-Lorenz & Bernadine Cimprich. (2012) Cognitive function and breast cancer: promise and potential insights from functional brain imaging. Breast Cancer Research and Treatment 137:1, pages 33-43.
Crossref
Crossref
Amanda D. Hutchinson, Jessica R. Hosking, Ganessan Kichenadasse, Julie K. Mattiske & Carlene Wilson. (2012) Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review. Cancer Treatment Reviews 38:7, pages 926-934.
Crossref
Crossref
Victoria A. Shaffer, Edgar C. Merkle, Angela Fagerlin, Jennifer J. Griggs, Kenneth M. Langa & Theodore J. Iwashyna. (2012) Chemotherapy Was Not Associated With Cognitive Decline in Older Adults With Breast and Colorectal Cancer. Medical Care 50:10, pages 849-855.
Crossref
Crossref
Rebecca Siegel, Carol DeSantis, Katherine Virgo, Kevin Stein, Angela Mariotto, Tenbroeck Smith, Dexter Cooper, Ted Gansler, Catherine Lerro, Stacey Fedewa, Chunchieh Lin, Corinne Leach, Rachel Spillers Cannady, Hyunsoon Cho, Steve Scoppa, Mark Hachey, Rebecca Kirch, Ahmedin Jemal & Elizabeth Ward. (2012) Cancer treatment and survivorship statistics, 2012. CA: A Cancer Journal for Clinicians 62:4, pages 220-241.
Crossref
Crossref
Heather S. L. Jim, Brent Small, Sheri Hartman, Jamie Franzen, Shannon Millay, Kristin Phillips, Paul B. Jacobsen, Margaret Booth‐Jones & Joseph Pidala. (2011) Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation. Cancer 118:13, pages 3407-3416.
Crossref
Crossref
Stephanie A. Reid-Arndt & Cathy R. Cox. (2012) Stress, Coping and Cognitive Deficits in Women After Surgery for Breast Cancer. Journal of Clinical Psychology in Medical Settings 19:2, pages 127-137.
Crossref
Crossref
Jacqueline Galica, Dale Rajacich, Debbie Kane & Gregory R. Pond. (2012) The Impact of Chemotherapy-Induced Cognitive Impairment on the Psychosocial Adjustment of Patients With Nonmetastatic Colorectal Cancer. Clinical Journal of Oncology Nursing 16:2, pages 163-169.
Crossref
Crossref
Michelle C. Janelsins, Karen M. Mustian, Oxana G. Palesh, Supriya G. Mohile, Luke J. Peppone, Lisa K. Sprod, Charles E. Heckler, Joseph A. Roscoe, Alan W. Katz, Jacqueline P. Williams & Gary R. Morrow. (2011) Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Supportive Care in Cancer 20:4, pages 831-839.
Crossref
Crossref
Stephanie A. Reid-Arndt, Sandy Matsuda & Cathy R. Cox. (2012) Tai Chi effects on neuropsychological, emotional, and physical functioning following cancer treatment: A pilot study. Complementary Therapies in Clinical Practice 18:1, pages 26-30.
Crossref
Crossref
Robert J. Ferguson, Brenna C. McDonald, Michael A. Rocque, Charlotte T. Furstenberg, Susan Horrigan, Tim A. Ahles & Andrew J. Saykin. (2010) Development of CBT for chemotherapy‐related cognitive change: results of a waitlist control trial. Psycho-Oncology 21:2, pages 176-186.
Crossref
Crossref
Summer F. Acevedo. (2012) Why, after Chemotherapy, is it Necessary to Assess Memory Using Translational Testing?. Breast Cancer: Basic and Clinical Research 6, pages BCBCR.S10293.
Crossref
Crossref
Diane Von Ah, Catherine Jansen, Deborah Hutchinson Allen, Rosalina M. Schiavone & Jennifer Wulff. (2011) Putting Evidence Into Practice. Clinical Journal of Oncology Nursing 15:6, pages 607-615.
Crossref
Crossref
Susan S. Tavernier, Annette M. Totten & Susan L. Beck. (2011) Assessing Content Validity of the Patient Generated Index Using Cognitive Interviews. Qualitative Health Research 21:12, pages 1729-1738.
Crossref
Crossref
Florence Joly, Olivier Rigal, Sabine Noal & Bénédicte Giffard. (2011) Cognitive dysfunction and cancer: which consequences in terms of disease management?. Psycho-Oncology 20:12, pages 1251-1258.
Crossref
Crossref
Michiel B. de Ruiter, Liesbeth Reneman, Willem Boogerd, Dick J. Veltman, Frits S.A.M. van Dam, Aart J. Nederveen, Epie Boven & Sanne B. Schagen. (2011) Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Human Brain Mapping 32:8, pages 1206-1219.
Crossref
Crossref
T. MITCHELL & P. TURTON. (2011) ‘Chemobrain’: concentration and memory effects in people receiving chemotherapy - a descriptive phenomenological study. European Journal of Cancer Care 20:4, pages 539-548.
Crossref
Crossref
Laura Lyons, Maha ElBeltagy, Jariya Umka, Rachel Markwick, Carla Startin, Geoffrey Bennett & Peter Wigmore. (2010) Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy. Psychopharmacology 215:1, pages 105-115.
Crossref
Crossref
Michelle Ayala-FelicianoJaime J. Pons-ValerioJosé Pons-MaderaSummer F. Acevedo. (2011) The Relationship between Visuospatial Memory and Coping Strategies in Breast Cancer Survivors. Breast Cancer: Basic and Clinical Research 5, pages BCBCR.S6957.
Crossref
Crossref
Janette Vardy & Haryana Dhillon. 2011. Supportive Oncology. Supportive Oncology
448
455
.
C. Nieder. 2011. Advances in Radiation Oncology in Lung Cancer. Advances in Radiation Oncology in Lung Cancer
647
658
.
Jamie S. Myers, Valmi D. Sousa & Heidi S. Donovan. (2010) Predictors of Self-Reported Memory Problems in Patients With Ovarian Cancer Who Have Received Chemotherapy. Oncology Nursing Forum 37:5, pages 596-603.
Crossref
Crossref
Stephanie A. Reid‐Arndt, Catherine Hsieh & Michael C. Perry. (2010) Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer. Psycho-Oncology 19:5, pages 535-544.
Crossref
Crossref
Michele R. Lucas. (2010) Psychosocial Implications for the Patient With a High-Grade Glioma. Journal of Neuroscience Nursing 42:2, pages 104-108.
Crossref
Crossref
Robert J. Ferguson, Anna G. Cassel & Rachel F. S. Dawson. (2010) Cognitive Effects of Cancer Chemotherapy in Adult Cancer Survivors: Cognitive-Behavioral Management. Journal of Rational-Emotive & Cognitive-Behavior Therapy 28:1, pages 25-41.
Crossref
Crossref
E.A. KVALE, O.J. CLAY, L.A. ROSS-MEADOWS, J.S. MCGEE, J.D. EDWARDS, F.W. UNVERZAGT, C.S. RITCHIE & K.K. BALL. (2010) Cognitive speed of processing and functional declines in older cancer survivors: an analysis of data from the ACTIVE trial. European Journal of Cancer Care 19:1, pages 110-117.
Crossref
Crossref
Jamie S. Myers. 2010. Chemo Fog. Chemo Fog
55
69
.
Jamie S. Myers. 2010. Chemo Fog. Chemo Fog
13
18
.
Christopher D. Aluise, Rukhsana Sultana, Jitbangjong Tangpong, Mary Vore, Daret St. Clair, Jeffrey A. Moscow & D. Allan Butterfield. 2010. Chemo Fog. Chemo Fog
147
156
.
Jörg Dietrich. 2010. Chemo Fog. Chemo Fog
77
85
.
Katrina Evens & Valerie S. Eschiti. (2009) Cognitive Effects of Cancer Treatment: "Chemo Brain" Explained. Clinical Journal of Oncology Nursing 13:6, pages 661-666.
Crossref
Crossref
Jamie S. Myers. (2009) Chemotherapy-Related Cognitive Impairment. Clinical Journal of Oncology Nursing 13:4, pages 413-421.
Crossref
Crossref
Janette Vardy. 2009. Adjuvant Therapy for Breast Cancer. Adjuvant Therapy for Breast Cancer
387
419
.
Mei-Ling Chen, Chih-Teng Yu & Chien-Hui Yang. (2008) Sleep disturbances and quality of life in lung cancer patients undergoing chemotherapy. Lung Cancer 62:3, pages 391-400.
Crossref
Crossref
Melissa Friedman & Mercedes Fernandez. 2009. Cognition and Cancer. Cognition and Cancer
228
238
.
Anna Rusiewicz, Katherine N. DuHamel, Jack Burkhalter, Jamie Ostroff, Gary Winkel, Eileen Scigliano, Esperanza Papadopoulos, Craig Moskowitz & William Redd. (2007) Psychological distress in long‐term survivors of hematopoietic stem cell transplantation. Psycho-Oncology 17:4, pages 329-337.
Crossref
Crossref
George Kannarkat, Erin E Lasher & David Schiff. (2007) Neurologic complications of chemotherapy agents. Current Opinion in Neurology 20:6, pages 719-725.
Crossref
Crossref
Mary E. Sesto, Panel Participants: K. Robin Yabroff, Cathy J. Bradley, Michael Feuerstein & Gregg C. Vanderheiden. (2016) Panel: The Need for System Solutions to Improve Employment Outcomes of Cancer Survivors. Proceedings of the Human Factors and Ergonomics Society Annual Meeting 51:16, pages 986-990.
Crossref
Crossref
Lisa M. Hess & Kathleen C. Insel. (2007) Chemotherapy-Related Change in Cognitive Function: A Conceptual Model. Oncology Nursing Forum 34:5, pages 981-994.
Crossref
Crossref
Janette Vardy & Ian Tannock. (2007) Cognitive function after chemotherapy in adults with solid tumours. Critical Reviews in Oncology/Hematology 63:3, pages 183-202.
Crossref
Crossref
Daniel H. S. Silverman, Christine J. Dy, Steven A. Castellon, Jasmine Lai, Betty S. Pio, Laura Abraham, Kari Waddell, Laura Petersen, Michael E. Phelps & Patricia A. Ganz. (2006) Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy. Breast Cancer Research and Treatment 103:3, pages 303-311.
Crossref
Crossref
Janette Vardy, Sean Rourke & Ian F. Tannock. (2007) Evaluation of Cognitive Function Associated With Chemotherapy: A Review of Published Studies and Recommendations for Future Research. Journal of Clinical Oncology 25:17, pages 2455-2463.
Crossref
Crossref
Daniel HS SilvermanSteven A Castellon & Patricia A Ganz. (2007) Cognitive dysfunction associated with chemotherapy for breast cancer. Future Neurology 2:3, pages 271-277.
Crossref
Crossref
Kerstin Hermelink, Michael Untch, Michael P. Lux, Rolf Kreienberg, Thomas Beck, Ingo Bauerfeind & Karin Münzel. (2007) Cognitive function during neoadjuvant chemotherapy for breast cancer. Cancer 109:9, pages 1905-1913.
Crossref
Crossref
Sadhna Kohli, Jennifer J. Griggs, Joseph A. Roscoe, Pascal Jean-Pierre, Christopher Bole, Karen M. Mustian, Renae Hill, Kelly Smith, Howard Gross & Gary R. Morrow. (2007) Self-Reported Cognitive Impairment in Patients With Cancer. Journal of Oncology Practice 3:2, pages 54-59.
Crossref
Crossref
T. MITCHELL. (2007) The social and emotional toll of chemotherapy ? patients' perspectives. European Journal of Cancer Care 16:1, pages 39-47.
Crossref
Crossref
Sheri R. Jacobs, Paul B. Jacobsen, Margaret Booth-Jones, Lynne I. Wagner & Claudio Anasetti. (2007) Evaluation of the Functional Assessment of Cancer Therapy Cognitive Scale with Hematopoetic Stem Cell Transplant Patients. Journal of Pain and Symptom Management 33:1, pages 13-23.
Crossref
Crossref
Robert J. Ferguson, Raine Riggs, Tim Ahles & Andrew J. Saykin. 2007. Handbook of Cancer Survivorship. Handbook of Cancer Survivorship
287
301
.
Andrea K. Bial, Richard L. Schilsky & Greg A. Sachs. (2006) Evaluation of cognition in cancer patients: Special focus on the elderly. Critical Reviews in Oncology/Hematology 60:3, pages 242-255.
Crossref
Crossref
Mary E. Sesto. (2016) Role of Human Factors Engineering in Improving Employment Outcomes among Cancer Survivors. Proceedings of the Human Factors and Ergonomics Society Annual Meeting 50:15, pages 1510-1513.
Crossref
Crossref
Deborah A. Boyle. (2006) Survivorship. Clinical Journal of Oncology Nursing 10:3, pages 407-422.
Crossref
Crossref
A. Scherwath, A. Mehnert, B. Schleimer, L. Schirmer, F. Fehlauer, R. Kreienberg, B. Metzner, E. Thiel, A.R. Zander, F. Schulz-Kindermann & U. Koch. (2006) Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects. Annals of Oncology 17:3, pages 415-423.
Crossref
Crossref
Tracey McCready. (2006)
Commentary on Schultz PN, Klein MJ, Beck ML, Stava C & Sellin RV (2005) Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors.
Journal of Clinical Nursing
14, 204-211
. Journal of Clinical Nursing 15:2, pages 238-239.
Crossref
Crossref
Elena Massa, Clelia Madeddu, Maria Rita Lusso, Giulia Gramignano & Giovanni Mantovani. (2006) Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy. Critical Reviews in Oncology/Hematology 57:2, pages 175-182.
Crossref
Crossref
Val Shilling, Valerie Jenkins & Ivonne Solis Trapala. (2005) The (mis)classification of chemo-fog – methodological inconsistencies in the investigation of cognitive impairment after chemotherapy. Breast Cancer Research and Treatment 95:2, pages 125-129.
Crossref
Crossref
Kari Staat & Milena Segatore. (2005) The Phenomenon of Chemo Brain. Clinical Journal of Oncology Nursing 9:6, pages 713-721.
Crossref
Crossref
Jimmie C. Holland & Inga Reznik. (2005) Pathways for psychosocial care of cancer survivors. Cancer 104:S11, pages 2624-2637.
Crossref
Crossref
Catherine E. Jansen, Christine Miaskowski, Marylin Dodd, Glenna Dowling & Joel Kramer. (2005) A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer 104:10, pages 2222-2233.
Crossref
Crossref
Catherine Jansen, Christine Miaskowski, Marylin Dodd, Glenna Dowling & Joel Kramer. (2005) Potential Mechanisms for Chemotherapy-Induced Impairments in Cognitive Function. Oncology Nursing Forum 32:6, pages 1151-1163.
Crossref
Crossref
Tomohiro Matsuda, Tomoko Takayama, Manabu Tashiro, Yu Nakamura, Yasuo Ohashi & Kojiro Shimozuma. (2005) Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients - evaluation of appropriate research design and methodology to measure symptoms. Breast Cancer 12:4, pages 279-287.
Crossref
Crossref
Steven A. Castellon, Daniel H. S. Silverman & Patricia A. Ganz. (2005) Breast Cancer Treatment and Cognitive Functioning: Current Status and Future Challenges in Assessment. Breast Cancer Research and Treatment 92:3, pages 199-206.
Crossref
Crossref
Martine Extermann, Hongbin Chen, Margaret Booth-Jones, Julie Meyer, Lodovico Balducci & Paul Jacobsen. (2005) Pilot testing of the computerized cognitive test Microcog™ in chemotherapy-treated older cancer patients. Critical Reviews in Oncology/Hematology 54:2, pages 137-143.
Crossref
Crossref
V. Shilling, V. Jenkins, R. Morris, G. Deutsch & D. Bloomfield. (2005) The effects of adjuvant chemotherapy on cognition in women with breast cancer—preliminary results of an observational longitudinal study. The Breast 14:2, pages 142-150.
Crossref
Crossref
Pamela N Schultz, Mary Jean Klein, Martha L Beck, Charles Stava & Rena V Sellin. (2005) Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors. Journal of Clinical Nursing 14:2, pages 204-211.
Crossref
Crossref
Carsten Nieder & Anca-Ligia Grosu. 2005. Advances in Radiation Oncology in Lung Cancer. Advances in Radiation Oncology in Lung Cancer
383
393
.
Bernadine Cimprich, Heeyoung So, David L. Ronis & Christine Trask. (2004) Pre‐treatment factors related to cognitive functioning in women newly diagnosed with breast cancer. Psycho-Oncology 14:1, pages 70-78.
Crossref
Crossref
Kati Copley-Merriman, Joseph Jackson, J. Gregory Boyer, Joseph C. Cappelleri, Robert DeMarinis, Joseph DiCesare, M. Haim Erder, Jean Paul Gagnon, Lou Garrison, Kathleen Gondek, Kim A. Heithoff, Tom Hughes, David Miller, Margaret Rothman, Nancy Santanello, Richard Willke & Bruce Wong. 2009. Outcomes Assessment in Cancer. Outcomes Assessment in Cancer
623
638
.
Thomas W. McAllister, Tim A. Ahles, Andrew J. Saykin, Robert J. Ferguson, Brenna C. McDonald, Lionel D. Lewis, Laura A. Flashman & C. Harker Rhodes. (2004) Cognitive effects of cytotoxic cancer chemotherapy: Predisposing risk factors and potential treatments. Current Psychiatry Reports 6:5, pages 364-371.
Crossref
Crossref
Dawn Hershman & Rashmi Narayanan. (2004) Prevention and management of osteoporosis in women with breast cancer and men with prostate cancer. Current Oncology Reports 6:4, pages 277-284.
Crossref
Crossref
Gregoris Iconomou, Vasiliki Mega, Angelos Koutras, Alexander V. Iconomou & Haralabos P. Kalofonos. (2004) Prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy. Cancer 101:2, pages 404-411.
Crossref
Crossref
Paul B Jacobsen, Linda L Garland, Margaret Booth-Jones, Kristine A Donovan, Christina L Thors, Erin Winters & Edward Grendys. (2004) Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy. Journal of Pain and Symptom Management 28:1, pages 7-18.
Crossref
Crossref
DAWN HERSHMAN, ELLEN RITCHIE & ZACHARY ROSNER. 2004. Principles of Gender-Specific Medicine. Principles of Gender-Specific Medicine
637
647
.
Linda Mileshkin, Yoland Antill & Danny Rischin. 2004. Gynecologic Cancer. Gynecologic Cancer
605
628
.
Terri Armstrong & Mark R. Gilbert. (2004) Central nervous system toxicity from cancer treatment. Current Oncology Reports 6:1, pages 11-19.
Crossref
Crossref
Hope S Rugo & Tim Ahles. (2003) The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research. Seminars in Oncology 30:6, pages 749-762.
Crossref
Crossref
CAY ANDERSON-HANLEY, MARNE L. SHERMAN, RAINE RIGGS, V. BEDE AGOCHA & BRUCE E. COMPAS. (2004) Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literature. Journal of the International Neuropsychological Society 9:7, pages 967-982.
Crossref
Crossref
R. Morse, J. Rodgers, M. Verrill & K. Kendell. (2003) Neuropsychological functioning following systemic treatment in women treated for breast cancer: a review. European Journal of Cancer 39:16, pages 2288-2297.
Crossref
Crossref
John M. Varlotto, John C. Flickinger, Ajay Niranjan, Ajay K. Bhatnagar, Douglas Kondziolka & L.Dale Lunsford. (2003) Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases. International Journal of Radiation Oncology*Biology*Physics 57:2, pages 452-464.
Crossref
Crossref
Tim A. Ahles, Andrew J. Saykin, Walter W. Noll, Charlotte T. Furstenberg, Stephen Guerin, Bernard Cole & Leila A. Mott. (2003) The relationship of APOE genotype to neuropsychological performance in long‐term cancer survivors treated with standard dose chemotherapy. Psycho-Oncology 12:6, pages 612-619.
Crossref
Crossref
Bernadine Cimprich & David L. Ronis. (2003) An Environmental Intervention to Restore Attention in Women With Newly Diagnosed Breast Cancer. Cancer Nursing 26:4, pages 284-292.
Crossref
Crossref
Robert J. Ferguson & Tim A. Ahles. (2003) Low neuropsychologic performance among adult cancer survivors treated with chemotherapy. Current Neurology and Neuroscience Reports 3:3, pages 215-222.
Crossref
Crossref
Karen Hassey Dow. (2003) Challenges and Opportunities in Cancer Survivorship Research. Oncology Nursing Forum 30:3, pages 455-469.
Crossref
Crossref
Debra Barton & Charles Loprinzi. (2002) Novel Approaches to Preventing Chemotherapy-Induced Cognitive Dysfunction in Breast Cancer: The Art of the Possible. Clinical Breast Cancer 3, pages S121-S127.
Crossref
Crossref
Tim A. Ahles & Andrew J. Saykin. (2002) Breast Cancer Chemotherapy-Related Cognitive Dysfunction. Clinical Breast Cancer 3, pages S84-S90.
Crossref
Crossref
. (2002) Current Awareness. Pharmacoepidemiology and Drug Safety 11:4, pages 345-360.
Crossref
Crossref
Tim A. AhlesAndrew J. SaykinCharlotte T. FurstenbergBernard ColeLeila A. MottKaren SkallaMarie B. WhedonSarah BivensTara MitchellE. Robert GreenbergPeter M. Silberfarb. (2002) Neuropsychologic Impact of Standard-Dose Systemic Chemotherapy in Long-Term Survivors of Breast Cancer and Lymphoma. Journal of Clinical Oncology 20:2, pages 485-493.
Crossref
Crossref
Jeremy C. Lundberg, Dale Theobald, Tim A. Ahles, Katharine P. Bailey & James R. Zabora. (2000) Screening to Identify and Treat Tamoxifen-Associated Side Effects. Cancer Practice 8:5, pages 211-214.
Crossref
Crossref